Drug 1 | |
Generic/Working Name | Afatinib |
Company Name | Boehringer‐Ingelheim |
Drug Type | Molecular targeting drug |
Drug Class | EGFR |
Dose | 40 milligrams (mg) per flat dose |
Route | Oral (p.o.) |
Schedule of Administration | Afatinib 40 mg was administered orally once a day until either disease progression or the incidence of prescribed AEs. |